Hypokalemia Dosage: Kalium Durule (Potassium Chloride)
For oral potassium replacement, administer 20-100 mEq per day in divided doses, with no more than 20 mEq given in a single dose; for intravenous replacement in severe hypokalemia, infuse 20-40 mEq over 1 hour via central line when possible, not exceeding 10 mEq/hour in non-urgent cases or up to 40 mEq/hour in life-threatening situations with continuous cardiac monitoring. 1, 2
Oral Potassium Replacement
Dosing Strategy:
- Prevention of hypokalemia: 20 mEq per day 1
- Treatment of potassium depletion: 40-100 mEq per day 1
- Critical rule: Divide doses so that no single dose exceeds 20 mEq 1
Administration specifics:
- Take with meals and a full glass of water—never on an empty stomach due to gastric irritation risk 1
- If swallowing is difficult, break tablets in half or prepare an aqueous suspension by dissolving in 4 oz water, waiting 2 minutes, stirring, and consuming immediately 1
The FDA label emphasizes that typical dietary potassium intake is 50-100 mEq daily, and hypokalemia requiring treatment usually represents a loss of 200+ mEq from total body stores 1. This context helps frame replacement needs.
Intravenous Potassium Replacement
Standard (Non-Urgent) Dosing:
Urgent/Severe Hypokalemia Dosing:
- Criteria: Serum K+ <2 mEq/L with ECG changes and/or muscle paralysis 2
- Maximum rate: Up to 40 mEq/hour 2
- Maximum 24-hour dose: 400 mEq 2
- Mandatory: Continuous ECG monitoring and frequent serum potassium checks 2
Route Selection and Safety
Central venous administration is strongly preferred because peripheral infusion causes significant pain and extravasation risk 2. The highest concentrations (300-400 mEq/L) must be given exclusively via central route 2.
Research evidence supports these aggressive rates in critical care settings. Studies demonstrate that concentrated potassium infusions (20 mEq in 100 mL over 1 hour, delivering 200 mEq/L concentration) are safe and effective in ICU patients, producing mean potassium increases of 0.5-1.1 mEq/L depending on dose 3, 4, 5. Importantly, these infusions decreased ventricular arrhythmias rather than causing them 4.
Critical Context: Cardiac Arrest Situations
In hypokalemic cardiac arrest, bolus potassium administration is contraindicated (Class III recommendation). 6 The AHA guidelines explicitly state that while hypokalemia can cause life-threatening arrhythmias and cardiac arrest, management is based on slow infusion over hours from historical case reports. The effect of bolus potassium in cardiac arrest is "unknown and ill advised" 6.
However, a 2022 narrative review challenges this, arguing that rapid IV potassium (10 mEq/100 mL over 5 minutes) may be warranted in hypokalemic cardiac arrest given the time-sensitive nature and need to treat a reversible cause 7. This represents evolving thinking but contradicts current guideline recommendations.
Practical Monitoring and Pitfalls
Common mistakes to avoid:
- Administering oral potassium on empty stomach (causes severe gastric irritation) 1
- Exceeding 20 mEq per single oral dose (increases GI side effects) 1
- Using peripheral IV for high concentrations (causes pain and tissue damage) 2
- Combining potassium supplements with ACE inhibitors/ARBs and potassium-sparing diuretics without careful monitoring (risk of dangerous hyperkalemia) 8
Essential monitoring:
- Serum potassium should be maintained at 4.5-5.0 mEq/L range, particularly in heart failure patients at risk for arrhythmias 8
- During IV infusion, check potassium levels at 15-minute intervals initially 4
- Continuous ECG monitoring is mandatory for rates exceeding 10 mEq/hour 2
- Much of administered potassium is excreted in urine even with persistent hypokalemia 9, so ongoing losses must be addressed
Renal function considerations: Research shows that potassium infusions produce similar peak levels regardless of renal function status 3, but patients with renal insufficiency require more cautious dosing and closer monitoring to avoid the most severe hyperkalemia cases 6.